Rockwell Collins Inc. is the foremost global supplier of communications and avionics equipment for both commercial and military customers. It follows a strategic acquisition program. Apart from its acquisition- driven growth strategy, Rockwell Collins remains focused to expand its product and service offering through continuous investments in research and development activities.
However, dependence on international sales, a highly competitive market and high exposure to fixed-price contracts raise concerns. In September 2017, Rockwell Collins signed a definitive agreement with United Technologies Corp. Per the deal, United Technologies will acquire Rockwell Collins for a total transaction value of $30 billion.
Estimate Trend & Surprise History
Rockwell Collins’ fiscal third quarter 2018 estimate has remained stable over last 7 days and the consensus estimate stands at $1.89.
Talking about the earnings surprise, Rockwell Collins came out with positive earnings surprise in three of the last four earnings reports marking an average positive surprise of 2.79%.
The company currently has a Zacks Rank #3 (Hold). Going further things could definitely change given the company’s recently released earnings results.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Rockwell Collins, Inc. Price and EPS Surprise
Rockwell Collins, Inc. Price and EPS Surprise | Rockwell Collins, Inc. Quote
Going below we have mentioned some of the vital information from this just-revealed announcement:
Earnings Beat: Rockwell Collins reported third-quarter fiscal 2018 adjusted earnings of $1.73 per share, which lagged behind the Zacks Consensus Estimate of $1.89.
Revenue Beat: The company also lagged behind the revenue expectations. Rockwell Collins posted revenues of $ 2,208 million for the fiscal third quarter, compared to our consensus estimate of $2,238 million.
Key Stats to Note: Rockwell Collins paid dividends worth $54 million in the reported quarter. As of June 30, 2018 cash provided by operating activities was $196 million compared to $416 million as on June 30, 2017.
Check back later for our full write up on this Rockwell Collins earnings report later!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Image: Bigstock
Rockwell Collins (COL) Misses Q3 Earnings & Revenue Estimates
Rockwell Collins Inc. is the foremost global supplier of communications and avionics equipment for both commercial and military customers. It follows a strategic acquisition program. Apart from its acquisition- driven growth strategy, Rockwell Collins remains focused to expand its product and service offering through continuous investments in research and development activities.
However, dependence on international sales, a highly competitive market and high exposure to fixed-price contracts raise concerns. In September 2017, Rockwell Collins signed a definitive agreement with United Technologies Corp. Per the deal, United Technologies will acquire Rockwell Collins for a total transaction value of $30 billion.
Estimate Trend & Surprise History
Rockwell Collins’ fiscal third quarter 2018 estimate has remained stable over last 7 days and the consensus estimate stands at $1.89.
Talking about the earnings surprise, Rockwell Collins came out with positive earnings surprise in three of the last four earnings reports marking an average positive surprise of 2.79%.
The company currently has a Zacks Rank #3 (Hold). Going further things could definitely change given the company’s recently released earnings results.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Rockwell Collins, Inc. Price and EPS Surprise
Rockwell Collins, Inc. Price and EPS Surprise | Rockwell Collins, Inc. Quote
Going below we have mentioned some of the vital information from this just-revealed announcement:
Earnings Beat: Rockwell Collins reported third-quarter fiscal 2018 adjusted earnings of $1.73 per share, which lagged behind the Zacks Consensus Estimate of $1.89.
Revenue Beat: The company also lagged behind the revenue expectations. Rockwell Collins posted revenues of $ 2,208 million for the fiscal third quarter, compared to our consensus estimate of $2,238 million.
Key Stats to Note: Rockwell Collins paid dividends worth $54 million in the reported quarter. As of June 30, 2018 cash provided by operating activities was $196 million compared to $416 million as on June 30, 2017.
Check back later for our full write up on this Rockwell Collins earnings report later!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>